Concepedia

Jacob Schachter

JS

Statistics

Publications

154

Citations

30.2K

H-Index

63

Active since

1984

Affiliations

Sheba Medical Center(Current)

Tel Aviv University

Melanoma Institute Australia

Institut Gustave Roussy

The University of Sydney

Jacob Schachter is an author at Sheba Medical Center specializing in oncology, medicine, and cancer immunotherapy.

Publications per year

1984–2024

154

Publications

154

Pembrolizumab versus Ipilimumab in Advanced Melanoma

Caroline Robert, Jacob Schachter, Georgina V. Long et al. · New England Journal of Medicine · 2015 · 5.8K citations · Full text

Life Sciences, Oncology, Pharmacotherapy +17

Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib

Caroline Robert, Bogusława Karaszewska, Jacob Schachter et al. · New England Journal of Medicine · 2014 · 2.7K citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients

Erez N. Baruch, Ilan Youngster, Guy Ben‐Betzalel et al. · Science · 2020 · 1.6K citations

Life Sciences, Immunology, Oncology +17

Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial

Antoni Ribas, Igor Puzanov, Reinhard Dummer et al. · The Lancet Oncology · 2015 · 1.6K citations · Full text

Medicine, Clinical Sciences, Oncology +15

Adjuvant Dabrafenib plus Trametinib in Stage III<i>BRAF</i>-Mutated Melanoma

Georgina V. Long, Axel Hauschild, Mario Santinami et al. · New England Journal of Medicine · 2017 · 1.5K citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

1–5 of 154